Clinical Trial Update: Addition of Pyridostigmine to Conventional Management of Postdural Puncture Headache [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated adding pyridostigmine to conventional management for post-dural puncture headache and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-dural Puncture Headache

Drugs mentioned

• Pyridostigmine (pyridostigmine)

Snippet

Sponsor: Ain Shams University | Conditions: Postdural Puncture Headache | Phase 4 | Status: COMPLETED